Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Pharmacy and Science

• Publication date

  2011-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jps.22448PMID 21213308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.

  2011cited by this paper
• Searching for conditions to form stable protein oligomers with amyloid-like characteristics: The unexplored basic pH.

  2010cited by this paper
• Domain-level stability of an antibody monitored by reduction, differential alkylation, and mass spectrometry analysis.

  2010cited by this paper
• Aggregation of a multidomain protein: A coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress

  2010cited by this paper
• Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.

  2010cited by this paper
• Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH, NaCl, and temperature for alpha-chymotrypsinogen A.

  2010cited by this paper
• Elucidation of two major aggregation pathways in an IgG2 antibody.

  2009cited by this paper
• Lumry-Eyring nucleated-polymerization model of protein aggregation kinetics. 2. Competing growth via condensation and chain polymerization.

  2009cited by this paper
• Characterization of high-molecular-weight nonnative aggregates and aggregation kinetics by size exclusion chromatography with inline multi-angle laser light scattering.

  2009cited by this paper
• Principles, approaches, and challenges for predicting protein aggregation rates and shelf life.

  2009cited by this paper
• Advances in predicting and manipulating the immunogenicity of biotherapeutics and vaccines.

  2009cited by this paper
• Therapeutic antibodies: successes, limitations and hopes for the future

  2009cited by this paper
• Protein aggregation: more than just fibrils.

  2009cited by this paper
• Engineered Human Antibody Constant Domains with Increased Stability*

  2009cited by this paper
• Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.

  2009cited by this paper
• Kinetic Analysis of Amyloid Formation in the Presence of Heparan Sulfate

  2009cited by this paper
• Kinetic folding studies of the P22 tailspike beta-helix domain reveal multiple unfolded states.

  2009cited by this paper
• Potential aggregation prone regions in biotherapeutics

  2009cited by this paper
• Protein folding forces.

  2008cited by this paper
• Determination of protein aggregation with differential mobility analysis: Application to IgG antibody

  2008cited by this paper
• Structure, formation and propagation of amyloid fibrils.

  2008cited by this paper
• Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.

  2008cited by this paper
• Lipid-derived aldehydes accelerate light chain amyloid and amorphous aggregation.

  2008cited by this paper
• Guiding protein aggregation with macromolecular crowding.

  2008cited by this paper
• Common motifs in protein self-assembly.

  2008cited by this paper
• Reversible and irreversible unfolding of multi-domain proteins.

  2007cited by this paper
• Non‐native protein aggregation kinetics

  2007cited by this paper
• Nonnative protein polymers: structure, morphology, and relation to nucleation and growth.

  2007cited by this paper
• Optimization of a Polyglutamine Aggregation Inhibitor Peptide (QBP1) Using a Thioflavin T Fluorescence Assay

  2007cited by this paper
• Amyloid fibril formation and disaggregation of fragment 1-29 of apomyoglobin: insights into the effect of pH on protein fibrillogenesis.

  2007cited by this paper
• A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding.

  2007cited by this paper
• Non-native aggregation of alpha-chymotrypsinogen occurs through nucleation and growth with competing nucleus sizes and negative activation energies.

  2007cited by this paper
• Protein aggregation and bioprocessing

  2006cited by this paper
• Methods for enhancing the accuracy and reproducibility of Congo red and thioflavin T assays.

  2006cited by this paper
• Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies

  2006cited by this paper
• A molecular-thermodynamic model for the interactions between globular proteins in aqueous solutions: applications to bovine serum albumin (BSA), lysozyme, alpha-chymotrypsin, and immuno-gamma-globulins (IgG) solutions.

  2006cited by this paper
• Effects of protein aggregates: An immunologic perspective

  2006cited by this paper
• Factors influencing the immunogenicity of therapeutic proteins.

  2005cited by this paper
• Template-directed self-assembly and growth of insulin amyloid fibrils.

  2005cited by this paper
• A consistent experimental and modeling approach to light-scattering studies of protein-protein interactions in solution.

  2005cited by this paper
• Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.

  2005cited by this paper
• Biochemistry (3rd ed.)

  2004cited by this paper
• Human antibody–Fc receptor interactions illuminated by crystal structures

  2004cited by this paper
• Conformational constraints for amyloid fibrillation: the importance of being unfolded.

  2004cited by this paper
• Principles of protein folding, misfolding and aggregation.

  2004cited by this paper
• Determination of protein charge by capillary zone electrophoresis.

  2004cited by this paper
• Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation

  2003cited by this paper
• In vitro unfolding, refolding, and polymerization of human γD crystallin, a protein involved in cataract formation

  2003cited by this paper
• Nativelike intermediate on the unfolding pathway of pig kidney fructose-1,6-bisphosphatase.

  2003cited by this paper
• Use of T4 lysozyme charge mutants to examine electrophoretic models.

  2002cited by this paper
• Measuring the size and charge of proteins using protein charge ladders, capillary electrophoresis, and electrokinetic models of colloids.

  2001cited by this paper
• Stability engineering of antibody single-chain Fv fragments.

  2001cited by this paper
• Reversibility of Scrapie-associated Prion Protein Aggregation*

  2001cited by this paper
• Revisiting the method of cumulants for the analysis of dynamic light-scattering data.

  2001cited by this paper
• The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein.

  2000cited by this paper
• High pressure fosters protein refolding from aggregates at high concentrations.

  1999cited by this paper
• Crystallographic structure of an intact IgG1 monoclonal antibody.

  1998cited by this paper
• Protein aggregation: folding aggregates, inclusion bodies and amyloid.

  1998cited by this paper
• Rules relating electrophoretic mobility, charge and molecular size of peptides and proteins.

  1997cited by this paper
• On the hydrodynamic analysis of macromolecular conformation.

  1995cited by this paper
• Thermodynamics of partly folded intermediates in proteins.

  1995cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Statistical Thermodynamics for Chemists and Biochemists

  1992cited by this paper
• An insight into domain structures and thermal stability of gamma-crystallins.

  1992cited by this paper
• Alternatively folded states of an immunoglobulin.

  1991cited by this paper
• Role of charge suppression and ionic strength in free zone electrophoresis of proteins.

  1991cited by this paper
• Extraction chemistry of fermentation product carboxylic acids.

  1986cited by this paper
• Stability of proteins. Proteins which do not present a single cooperative system.

  1982cited by this paper
• Stability of proteins: small globular proteins.

  1979cited by this paper
• Statistical Mechanics (2nd edn)

  1977cited by this paper
• Principles of colloid and surface chemistry

  1977cited by this paper
• Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants

  1972cited by this paper
• Viscosity and density of aqueous solutions of urea and guanidine hydrochloride.

  1966cited by this paper
• The cataphoresis of suspended particles. Part I.—The equation of cataphoresis

  1931cited by this paper

• Interdomain Interactions Modulate Refolding Kinetics and Aggregation in a Monoclonal Antibody

  2025cites this paper
• A fluorescent dye assay for antibody aggregates and its application in aggregate stability evaluation

  2025cites this paper
• Deep Learning-Based Prediction and Suppression of Protein Aggregation- Prone Regions

  2025cites this paper
• High‐throughput system for the thermostability analysis of proteins

  2024cites this paper
• Stability of Protein Pharmaceuticals: Recent Advances

  2024cites this paper
• Exploring the structural heterogeneity of IgG1s: A comprehensive analysis of glycosylated and deglycosylated forms using TIMS-TOF-MS technique

  2024cites this paper
• Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations

  2023cites this paper
• Nanoparticle protein corona: from structure and function to therapeutic targeting

  2023cites this paper
• Blueprint for antibody biologics developability

  2023cites this paper
• Decreasing hydrophobicity or shielding hydrophobic areas of CH2 attenuates low pH-induced IgG4 aggregation

  2023cites this paper
• Critical evaluation of fluorescent dyes to evaluate the stability and ligand binding properties of an anti-cocaine mAb, h2E2.

  2022cites this paper
• Predicting Experimental B22 Values and the Effects of Histidine Charge States for Monoclonal Antibodies Using Coarse-Grained Molecular Simulations.

  2022cites this paper
• Effects of Salts and Surface Charge on the Biophysical Stability of a low pI Monoclonal Antibody.

  2022cites this paper
• Nucleation in protein aggregation in biotherapeutic development: a look into the heart of the event.

  2022cites this paper
• High-Pressure, Low-Temperature Induced Unfolding and Aggregation of Monoclonal Antibodies: Role of the Fc and Fab Fragments.

  2022cites this paper
• ATP and Tri-Polyphosphate (TPP) Suppress Protein Aggregate Growth by a Supercharging Mechanism

  2021cites this paper
• Expanding the toolbox for predictive parameters describing antibody stability considering thermodynamic and kinetic determinants

  2021cites this paper
• In Situ Monitoring of Protein Unfolding/Structural States under Cold High-Pressure Stress.

  2021cites this paper
• Insights into the conformation and self-association of a concentrated monoclonal antibody using isothermal chemical denaturation and nuclear magnetic resonance.

  2021cites this paper
• Frontiers in Protein Structure, Function, and Dynamics

  2020cites this paper
• Protein A-based ligands for affinity chromatography of antibodies

  2020cites this paper
• Management of Insulin Through Co-Solute Engineering: A Therapeutic Approach

  2020cites this paper
• Storage stability of soy protein isolate powders containing soluble protein aggregates formed at varying pH

  2020cites this paper
• Toward Drug-Like Multispecific Antibodies by Design

  2020cites this paper
• Thermodynamic Unfolding and Aggregation Fingerprints of Monoclonal Antibodies Using Thermal Profiling

  2020cites this paper
• Kinetics and competing mechanisms of antibody aggregation via bulk and surface-mediated pathways.

  2020cites this paper
• Surfaces Affect Screening Reliability in Formulation Development of Biologics

  2020cites this paper
• The molecular interaction process.

  2020cites this paper
• Measuring Nonspecific Protein-Protein Interactions by Dynamic Light Scattering.

  2019cites this paper
• Arginine to lysine mutations increase the aggregation stability of a single chain variable fragment through unfolded state interactions.

  2019cites this paper
• Characterization of Cetuximab F c/2 aggregates by Offline CZE-MS

  2019cites this paper
• Modelling of pH-dependence to develop a strategy for stabilising mAbs at acidic steps in production

  2019cites this paper
• Stress Factors in Monoclonal Antibody Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy.

  2019cites this paper
• Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification

  2019cites this paper
• Science and Art of Protein Formulation Development.

  2019cites this paper
• Dynamic Measurements of Bovine Serum Albumin Aggregation Using Small Angle Neutron Scattering

  2018cites this paper
• Protein aggregation - Mechanisms, detection, and control.

  2018cites this paper
• Modification of the kinetic stability of immunoglobulin G by solvent additives

  2018cites this paper
• Characterization of therapeutic proteins by capillary electrophoresis (CE) coupled to mass spectrometry (MS)

  2017cites this paper
• The effect of charge mutations on the stability and aggregation of a human single chain Fv fragment

  2017cites this paper
• Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scattering

  2017cites this paper
• Formation of multimeric antibodies for self-delivery of active monomers

  2017cites this paper
• A change in the pathway of dithiothreitol-induced aggregation of bovine serum albumin in the presence of polyamines and arginine.

  2017cites this paper
• Modulation of the Kinetic Stability of Immunoglobulin G by Solvent Additives

  2016cites this paper
• Modulating non-native aggregation and electrostatic protein-protein interactions with computationally designed single-point mutations.

  2016cites this paper
• Characterization of cetuximab Fc/2 dimers by off-line CZE-MS.

  2016cites this paper
• Relating Protein-Protein Interactions and Aggregation Rates From Low to High Concentrations.

  2016cites this paper
• Development of asymmetrical flow field-flow fractionation for the characterization of proteins, protein aggregation, and nanoparticles

  2016cites this paper
• Fibpredictor: a computational method for rapid prediction of amyloid fibril structures

  2016cites this paper
• Coarse-Grained Antibody Models for "Weak" Protein-Protein Interactions from Low to High Concentrations.

  2016cites this paper
• Aggregation of Antibody Drug Conjugates at Room Temperature: SAXS and Light Scattering Evidence for Colloidal Instability of a Specific Subpopulation.

  2016cites this paper
• Identifying protein aggregation mechanisms and quantifying aggregation rates from combined monomer depletion and continuous scattering.

  2016cites this paper
• Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions

  2016cites this paper
• Facile Preparation of Stable Antibody-Gold Conjugates and Application to Affinity-Capture Self-Interaction Nanoparticle Spectroscopy.

  2016cites this paper
• Probing Submicron Aggregation Kinetics of an IgG Protein by Asymmetrical Flow Field-Flow Fractionation.

  2016cites this paper
• Acid-induced aggregation propensity of nivolumab is dependent on the Fc

  2016cites this paper
• The Application of Hydrogen/Deuterium Exchange and Covalent Labeling Coupled with Mass Spectrometry to Examine Protein Structure

  2016cites this paper
• Osmolyte Effects on Monoclonal Antibody Stability and Concentration-Dependent Protein Interactions with Water and Common Osmolytes.

  2016cites this paper
• Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.

  2016cites this paper
• A comparison of biophysical characterization techniques in predicting monoclonal antibody stability

  2016cites this paper
• Biophysical characterization of folding and aggregation behavior in model single- and multi-domain proteins

  2016cites this paper
• Colloidal Instability Fosters Agglomeration of Subvisible Particles Created by Rupture of Gels of a Monoclonal Antibody Formed at Silicone Oil-Water Interfaces.

  2016cites this paper
• Interactions between therapeutic protein formulations and surfaces

  2015cites this paper
• A multiscale view of therapeutic protein aggregation: A colloid science perspective

  2015cites this paper
• Prediction of colloidal stability of high concentration protein formulations

  2015cites this paper
• Resolving power of dynamic light scattering for protein and polystyrene nanoparticles

  2015cites this paper
• Investigating Therapeutic Protein Structure with Diethylpyrocarbonate Labeling and Mass Spectrometry.

  2015cites this paper
• Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.

  2015cites this paper
• Heterogeneous glycoform separation by process chromatography: I: Monomer purification and characterization.

  2015cites this paper
• Protein adsorption, desorption, and aggregation mediated by solid-liquid interfaces.

  2015cites this paper
• Specific-ion effects on the aggregation mechanisms and protein-protein interactions for anti-streptavidin immunoglobulin gamma-1.

  2015cites this paper
• Aggregate structure, morphology and the effect of aggregation mechanisms on viscosity at elevated protein concentrations.

  2015cites this paper
• Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.

  2015cites this paper
• Charakterisierung eines pharmazeutischen Antikörpers und geeigneter Aufreinigungsmethoden

  2015cites this paper
• Characterization of Monoclonal Antibody Aggregates and Emerging Technologies

  2015cites this paper
• pH- and temperature-dependent mechanisms of non-native aggregation of anti-CD40 IgG1

  2015cites this paper
• Mechanistic insights into the role of protein interactions on the aggregation behavior of anti-streptavidin immunoglobulin gamma-1

  2015cites this paper
• Role of domain unfolding and silicone oil-water interface in aggregation of a monoclonal antibody

  2015cites this paper
• Biopharmaceutical Informatics: Applications of Computation in Biologic Drug Development

  2015cites this paper
• Preclinical and clinical formulation studies

  2015cites this paper
• Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1

  2015influential citation
• Structural Changes and Aggregation Mechanisms for Anti-Streptavidin IgG1 at Elevated Concentration.

  2015cites this paper
• Improving monoclonal antibody selection and engineering using measurements of colloidal protein interactions.

  2014cites this paper
• Aggregates of α‐chymotrypsinogen anneal to access more stable states

  2014cites this paper
• Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass.

  2014cites this paper
• Utilization of Zwitterion-based solutions to dissect the relative effects of solution pH and ionic strength on the aggregation behavior and conformational stability of a fusion protein.

  2014cites this paper
• Partial unfolding of a monoclonal antibody: role of a single domain in driving protein aggregation.

  2014cites this paper
• Competing aggregation pathways for monoclonal antibodies

  2014cites this paper
• Nucleation, Aggregation, and Conformational Distortion

  2014cites this paper
• Biophysical Methods Applied in Early Discovery of a Biotherapeutic: Case Study of an Egfr‐Igf1R Bispecific Adnectin

  2014cites this paper
• High-Throughput Screening and Stability Optimization of Anti-Streptavidin IgG1 and IgG2 Formulations

  2014cites this paper
• Quantifying the impact of the physical environment during processing and storage of biopharmaceuticals

  2014cites this paper
• Avoiding antibody aggregation during processing: Establishing hold times

  2014cites this paper
• APPLIED IN EARLY DISCOVERY OF A BIOTHERAPEUTIC : CASE STUDY OF AN EGFR-IGF 1 R BISPECIFIC ADNECTIN

  2014cites this paper
• Therapeutic protein aggregation: mechanisms, design, and control.

  2014cites this paper
• Confocal Raman characterization of different protein desorption behaviors from chromatographic particles.

  2014cites this paper
• Theory and practice of size exclusion chromatography for the analysis of protein aggregates.

  2014cites this paper
• Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.

  2013cites this paper
• Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.

  2013cites this paper
• Multiequilibria of oligomeric thermophilic DNA replication polymerases

  2013cites this paper